APA

Zhou D., Podoll T., Xu Y., Moorthy G., Vishwanathan K., Ware J., Slatter J. G. & Al-Huniti N. (20200812). Evaluation of the Drug-Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP-5862, Using a Physiologically-Based Pharmacokinetic Modeling Approach. : CPT: pharmacometrics & systems pharmacology.

Chicago

Zhou Diansong, Podoll Terry, Xu Yan, Moorthy Ganesh, Vishwanathan Karthick, Ware Joseph, Slatter J Greg and Al-Huniti Nidal. 20200812. Evaluation of the Drug-Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP-5862, Using a Physiologically-Based Pharmacokinetic Modeling Approach. : CPT: pharmacometrics & systems pharmacology.

Harvard

Zhou D., Podoll T., Xu Y., Moorthy G., Vishwanathan K., Ware J., Slatter J. G. and Al-Huniti N. (20200812). Evaluation of the Drug-Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP-5862, Using a Physiologically-Based Pharmacokinetic Modeling Approach. : CPT: pharmacometrics & systems pharmacology.

MLA

Zhou Diansong, Podoll Terry, Xu Yan, Moorthy Ganesh, Vishwanathan Karthick, Ware Joseph, Slatter J Greg and Al-Huniti Nidal. Evaluation of the Drug-Drug Interaction Potential of Acalabrutinib and Its Active Metabolite, ACP-5862, Using a Physiologically-Based Pharmacokinetic Modeling Approach. : CPT: pharmacometrics & systems pharmacology. 20200812.